To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program.

This bill would change the rules about which specific types of medicines called "engineered cyclic peptides" count as qualifying single source drugs under the Drug Price Negotiation Program, which is a government program that negotiates prices for certain prescription drugs covered by Social Security health programs. No official summary is available for this bill.

Your Vote